Abstract Body

Background: CD163, a monocyte- and macrophage-specific scavenger receptor, is shed from the cell surface as soluble CD163 (sCD163) during activation. Monocyte/macrophage activation may contribute to on-going low-grade inflammation in human immunodeficiency virus (HIV)-infected patients. We therefore investigated the role of monocyte activation by measuring sCD163 levels in relation to outcome from HIV infection.

Methods: Plasma sCD163 levels were measured in 794 individuals with HIV infection in 2004/5. The prognostic value of sCD163 was evaluated by Cox proportional hazards regression analysis after adjustment for other risk factors. Kaplan-Meier survival curves were constructed for 0-30, 31-60, 61-90 and 91-100 percentiles. All values are median and interquartile range.

Results: Individuals were 42 (IQR: 37-50) years old and 72% were male. 43% were men who had sex with men (MSM), 36% were heterosexuals (HSX) and 15% injection drug users (IDU). 86% were receiving antiretroviral treatment (ART). Baseline CD4 T cell count was 502 (348-705) per µl and HIV RNA <20 (<20-87) copies/mL. Plasma sCD163 was 3.39 (2.27-5.07) mg/L. During 8.4 (8.1-8.8) years of follow up, there were 67 deaths (8.4%). Individuals who died had significantly higher sCD163 levels than survivors. In adjusted analysis, the mortality increase per mg of sCD163 was 8% (Hazard rate (HR): 1.08, 95% confidence interval (CI): 1.05-1.12). Age (HR: 1.07 (95% CI: 1.05-1.10) per year increment) and IDU vs. no IDU (HR: 2.30 (95% CI: 1.27-4.15) were other independent predictors of death while higher CD4 T cell counts (HR: 0.18 (95% CI: 0.09-0.37) per log increment) were associated with a decreased risk of death. In time-updated analysis, ART did not affect outcome (HR: 1.32 (0.59-2.95). The top 10% group of sCD163 had a 5-fold increased risk of death compared to the lowest 30% group (HR: 5.75 (95% CI: 2.20-15.02) (Figure 1).

Conclusions: The study verifies a clear association between the scavenger receptor system of macrophages and survival in HIV-infected individuals suggested by previous studies. It is the first to demonstrate a highly significant increase in mortality among HIV-infected individuals with an excessive activation of their monocyte/macrophage system. Our findings show that sCD163 is a novel prognostic marker and suggest that monitoring monocyte/macrophage activation may be important in HIV infection.

viewer?TAG_ACTION=SECURE_FILE_DOWNLOAD&V